|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Regencell Bioscience (NASDAQ: RGC) through any online brokerage.
There are no as such competitors for Regencell Bioscience.
The latest price target for Regencell Bioscience (NASDAQ: RGC) was reported by B. Riley Securities on January 2, 2018. The analyst firm set a price target for 0.00 expecting RGC to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Regencell Bioscience (NASDAQ: RGC) is $14.83 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Regencell Bioscience. The last dividend paid out to investors was $0.04 on February 16, 2018.
Regencell Bioscience’s $Q3 earnings are confirmed for after-market on $November 5, 2021.
There is no upcoming split for Regencell Bioscience.
Regencell Bioscience is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.